Abound Bio Company Profile, Contacts & Intelligence

Abound Bio Overview

Abound Bio is a company whose mission is to generate novel antibody-based biological therapeutics to meet unmet medical needs in the fields of cancer and infectious disease. Abound Bio is led by world renowned experts in the therapeutic antibody, infectious disease, and cancer space with a significant track record of successful development of biotherapeutics, licensing, and partnerships. In 2022, Abound Bio was acquired by Galapagos, a fully integrated biotechnology company. Since then, they have been united around a single purpose: to transform patient outcomes through life-changing science and innovation for more years of life and quality of life. As a result, we will be sharing all company updates, news, and insights on the Galapagos’ page as of now. Please follow Galapagos to stay updated on our latest developments and join our vibrant community. This page will stay online for cv referencing and historic purposes but will not be used to communicate updates. For details on the acquisition, please read our press release from 22 June 2022: https://www.glpg.com/press-release/3637/galapagos-to-acquire-cellpoint-and-aboundbio-to-accelerate-access-to-next-generation-cell-therapies

Headquarters

Pittsburgh, Pennsylvania, United States

Website

aboundbio.com

Industry

Biotechnology Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Abound Bio Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Abound Bio People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to Abound Bio

Explore companies in related markets and compare their industry and employee estimates.